UNITED STATES 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


SCHEDULE 14A
(RULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

 


Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

 

Filed by the Registrant

☒

   

Filed by a Party other than the Registrant

☐

 

Check the appropriate box:

☐

Preliminary Proxy Statement

☐

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)

☐

Definitive Proxy Statement

☒

Definitive Additional Materials

☐

Soliciting Material Pursuant to § 240.14a-12

 

INTERPACE DIAGNOSTICS GROUP, INC.

(Name of Registrant as Specified in Its Charter)

 

NOT APPLICABLE

(Name of Person(s) Filing Proxy Statement, if other than the registrant)

 

 
 
 

 

Payment of Filing Fee (Check the appropriate box):

☒

No fee required.

   

☐

Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

 

1)

Title of each class of securities to which transaction applies:

     
     
 

2)

Aggregate number of securities to which transaction applies:

     
     
 

3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

     
     
 

4)

Proposed maximum aggregate value of transaction:

     
     
 

5)

Total fee paid:

     
     

☐

Fee paid previously with preliminary materials.

   

☐

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

1)

Amount Previously Paid:

     
     
 

2)

Form, Schedule or Registration Statement No.:

     
     
 

3)

Filing Party:

     
     
 

4)

Date Filed:

     

 

 
 
 

 

 

 

July 25, 2016

 

 

Dear Stockholder:

 

We have previously sent to you proxy material for the Annual Meeting of Stockholders of Interpace Diagnostics Group, Inc. to be held on August 3, 2016. Your Board of Directors unanimously recommends that stockholders vote FOR all items on the agenda.

 

Your vote is important, no matter how many or how few shares you may own. If you have not already done so, please vote TODAY by telephone, via the Internet, or by signing, dating and returning the enclosed proxy card in the envelope provided.

 

Very truly yours,

 

Jack E. Stover

Chief Executive Officer

 

 

 

 

REMEMBER:

You can vote your shares by telephone, or via the Internet.

Please follow the instructions on the enclosed proxy card.

 

If you have any questions, or need assistance in voting

your shares, please call our proxy solicitor,

 

INNISFREE M&A INCORPORATED

TOLL-FREE, at 1-888-750-5834.